19
Participants
Start Date
March 21, 2022
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2028
Sotorasib
AMG510 (Sotorasib) is small molecule that specifically and irreversibly inhibits the KRAS-G12C mutant protein. AMG510 (Sotorasib) finished product is presented as tablets containing 120mg and will be packaged in bottles of 120 tablets.
RECRUITING
Hospitalario Universitario A Coruña, A Coruña
RECRUITING
ICO Girona, Hospital Josep Trueta, Girona
RECRUITING
Hospital Clínico San Cecilio De Granada, Granada
RECRUITING
Complejo Hospitalario De Jaén, Jaén
RECRUITING
Hospital Universitario Lucus Augusti, Lugo
RECRUITING
Hospital Clínico San Carlos, Madrid
RECRUITING
Hospital Universitario Fundación Jiménez Díaz, Madrid
RECRUITING
Hospital Universitario Puerta de Hierro, Majadahonda
RECRUITING
Hospital Universitario Severo Ochoa, Leganés
RECRUITING
Hospital Universitario Virgen Del Rocio, Seville
RECRUITING
Hospital General Universitario De Valencia, Valencia
RECRUITING
Hospital Universitario La Fe, Valencia
RECRUITING
Hospital De Basurto, Bilbao
RECRUITING
ICO Badalona, Hospital Germans Trias i Pujol, Badalona
RECRUITING
Hospital de Son Espases, Palma de Mallorca
RECRUITING
Hospital General Universitario de Alicante, Alicante
RECRUITING
Hospital Universitari Quiron Dexeus, Barcelona
RECRUITING
Hospital Universitari Vall d' Hebron, Barcelona
RECRUITING
Hospital Parc Taulí, Barcelona
RECRUITING
Hospital Universitari Son Llatzer, Palma de Mallorca
Fundación GECP
OTHER